Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Neurodegenerative Diseases is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. The research provides insights for the global Neurodegenerative Diseases market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Neurodegenerative Diseases industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Neurodegenerative Diseases Market Segmentations:
By Players:
Boehringer Ingelheim
Teva
AstraZeneca
Amarin
UCB
Merck
Pfizer
Addex Pharmaceutical
Bayer
Bial
Biogen Idec
Yumanity Therapeutics
Asubio Pharmaceutical
HLundbeck A/S
Eisai
H.Lundbeck A/S
Alector
By Types:
NMDA
SSRIs
Dopamine Inhibitors
By End-User:
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurodegenerative Diseases Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Neurodegenerative Diseases Market Share by Types
1.3.2 Global Neurodegenerative Diseases Market Size and Growth Rate of NMDA from 2014 to 2026
1.3.3 Global Neurodegenerative Diseases Market Size and Growth Rate of SSRIs from 2014 to 2026
1.3.4 Global Neurodegenerative Diseases Market Size and Growth Rate of Dopamine Inhibitors from 2014 to 2026
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Neurodegenerative Diseases Market Share by End-Users
1.4.2 Global Neurodegenerative Diseases Market Size and Growth Rate of Parkinson’s Disease from 2014 to 2026
1.4.3 Global Neurodegenerative Diseases Market Size and Growth Rate of Huntington Disease from 2014 to 2026
1.4.4 Global Neurodegenerative Diseases Market Size and Growth Rate of Amyotrophic Lateral Sclerosis from 2014 to 2026
1.4.5 Global Neurodegenerative Diseases Market Size and Growth Rate of Alzheimer’s Disease from 2014 to 2026
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.1.1 United States Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.1.2 Canada Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.1.3 Mexico Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.1 Germany Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.2 UK Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.3 France Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.4 Italy Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.5 Nordic Countries Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.6 Spain Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.7 Belgium Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.8 Poland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.9 Russia Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.10 Turkey Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.1 China Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.2 Japan Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.3 Australia and New Zealand Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.4 India Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.5 ASEAN Countries Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.6 South Korea Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Latin America, Middle East & Africa Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.1 GCC Countries Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.2 Brazil Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.3 Nigeria Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.4 South Africa Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.5 Argentina Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Neurodegenerative Diseases Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Neurodegenerative Diseases by Major Types
3.4.1 Market Size and Growth Rate of NMDA
3.4.2 Market Size and Growth Rate of SSRIs
3.4.3 Market Size and Growth Rate of Dopamine Inhibitors
4 Segmentation of Neurodegenerative Diseases Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Neurodegenerative Diseases by Major End-Users
4.4.1 Market Size and Growth Rate of Neurodegenerative Diseases for Parkinson’s Disease
4.4.2 Market Size and Growth Rate of Neurodegenerative Diseases for Huntington Disease
4.4.3 Market Size and Growth Rate of Neurodegenerative Diseases for Amyotrophic Lateral Sclerosis
4.4.4 Market Size and Growth Rate of Neurodegenerative Diseases for Alzheimer’s Disease
5 Market Analysis by Major Regions
-
5.1 Global Neurodegenerative Diseases Production Analysis by Major Regions
-
5.2 Global Neurodegenerative Diseases Consumption Analysis by Major Regions
-
5.3 Global Neurodegenerative Diseases Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
6 Product Commodity of Neurodegenerative Diseases Market in Major Countries
-
6.1 Top 5 Export Countries in Neurodegenerative Diseases market from 2014 to 2019
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.2 Top 5 Import Countries in Neurodegenerative Diseases market from 2014 to 2019
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Neurodegenerative Diseases Landscape Analysis
-
7.1 North America Neurodegenerative Diseases Landscape Analysis by Major Types
-
7.2 North America Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
7.3 North America Neurodegenerative Diseases Landscape Analysis by Major Countries
-
7.3.1 United States Neurodegenerative Diseases Market Volume and Growth Rate
-
7.3.2 Canada Neurodegenerative Diseases Market Volume and Growth Rate
-
7.3.3 Mexico Neurodegenerative Diseases Market Volume and Growth Rate
8 Europe Neurodegenerative Diseases Landscape Analysis
-
8.1 Europe Neurodegenerative Diseases Landscape Analysis by Major Types
-
8.2 Europe Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
8.3 Europe Neurodegenerative Diseases Landscape Analysis by Major Countries
-
8.3.1 Germany Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.2 UK Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.3 France Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.4 Italy Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.5 Nordic Countries Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.6 Spain Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.7 Belgium Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.8 Poland Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.9 Russia Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.10 Turkey Neurodegenerative Diseases Market Volume and Growth Rate
9 Asia Pacific Neurodegenerative Diseases Landscape Analysis
-
9.1 Asia Pacific Neurodegenerative Diseases Landscape Analysis by Major Types
-
9.2 Asia Pacific Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Neurodegenerative Diseases Landscape Analysis by Major Countries
-
9.3.1 China Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.2 Japan Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.4 India Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.6 South Korea Neurodegenerative Diseases Market Volume and Growth Rate
10 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis
-
10.1 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.2 Brazil Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.3 Nigeria Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.4 South Africa Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.5 Argentina Neurodegenerative Diseases Market Volume and Growth Rate
11 Major Players Profile
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Profile and Development Status
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Teva
11.2.1 Teva Company Profile and Development Status
11.2.2 Market Performance
11.2.3 Product and Service Introduction
11.3 AstraZeneca
11.3.1 AstraZeneca Company Profile and Development Status
11.3.2 Market Performance
11.3.3 Product and Service Introduction
11.4 Amarin
11.4.1 Amarin Company Profile and Development Status
11.4.2 Market Performance
11.4.3 Product and Service Introduction
11.5 UCB
11.5.1 UCB Company Profile and Development Status
11.5.2 Market Performance
11.5.3 Product and Service Introduction
11.6 Merck
11.6.1 Merck Company Profile and Development Status
11.6.2 Market Performance
11.6.3 Product and Service Introduction
11.7 Pfizer
11.7.1 Pfizer Company Profile and Development Status
11.7.2 Market Performance
11.7.3 Product and Service Introduction
11.8 Addex Pharmaceutical
11.8.1 Addex Pharmaceutical Company Profile and Development Status
11.8.2 Market Performance
11.8.3 Product and Service Introduction
11.9 Bayer
11.9.1 Bayer Company Profile and Development Status
11.9.2 Market Performance
11.9.3 Product and Service Introduction
11.10 Bial
11.10.1 Bial Company Profile and Development Status
11.10.2 Market Performance
11.10.3 Product and Service Introduction
11.11 Biogen Idec
11.11.1 Biogen Idec Company Profile and Development Status
11.11.2 Market Performance
11.11.3 Product and Service Introduction
11.12 Yumanity Therapeutics
11.12.1 Yumanity Therapeutics Company Profile and Development Status
11.12.2 Market Performance
11.12.3 Product and Service Introduction
11.13 Asubio Pharmaceutical
11.13.1 Asubio Pharmaceutical Company Profile and Development Status
11.13.2 Market Performance
11.13.3 Product and Service Introduction
11.14 HLundbeck A/S
11.14.1 HLundbeck A/S Company Profile and Development Status
11.14.2 Market Performance
11.14.3 Product and Service Introduction
11.15 Eisai
11.15.1 Eisai Company Profile and Development Status
11.15.2 Market Performance
11.15.3 Product and Service Introduction
11.16 H.Lundbeck A/S
11.16.1 H.Lundbeck A/S Company Profile and Development Status
11.16.2 Market Performance
11.16.3 Product and Service Introduction
11.17 Alector
11.17.1 Alector Company Profile and Development Status
11.17.2 Market Performance
11.17.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 92 Figures and 164 Tables)
-
Figure Product Picture
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of NMDA from 2014 to 2026
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of SSRIs from 2014 to 2026
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Dopamine Inhibitors from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Parkinson’s Disease from 2014 to 2026
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Huntington Disease from 2014 to 2026
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Amyotrophic Lateral Sclerosis from 2014 to 2026
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Alzheimer’s Disease from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure North America Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure United States Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure UK Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure France Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure China Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Australia and New Zealand Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure India Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Countries Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nigeria Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Neurodegenerative Diseases Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Neurodegenerative Diseases
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Neurodegenerative Diseases by Different Types from 2014 to 2026
-
Table Consumption Share of Neurodegenerative Diseases by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of NMDA
Figure Market Size and Growth Rate of SSRIs
Figure Market Size and Growth Rate of Dopamine Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Neurodegenerative Diseases by Different End-Users from 2014 to 2026
-
Table Consumption Share of Neurodegenerative Diseases by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Parkinson’s Disease
Figure Market Size and Growth Rate of Huntington Disease
Figure Market Size and Growth Rate of Amyotrophic Lateral Sclerosis
Figure Market Size and Growth Rate of Alzheimer’s Disease
-
Table Global Neurodegenerative Diseases Production by Major Regions
-
Table Global Neurodegenerative Diseases Production Share by Major Regions
-
Figure Global Neurodegenerative Diseases Production Share by Major Regions in 2014
-
Figure Global Neurodegenerative Diseases Production Share by Major Regions in 2018
-
Figure Global Neurodegenerative Diseases Production Share by Major Regions in 2026
-
Table Global Neurodegenerative Diseases Consumption by Major Regions
-
Table Global Neurodegenerative Diseases Consumption Share by Major Regions
-
Figure Global Neurodegenerative Diseases Consumption Share by Major Regions in 2014
-
Figure Global Neurodegenerative Diseases Consumption Share by Major Regions in 2018
-
Figure Global Neurodegenerative Diseases Consumption Share by Major Regions in 2026
-
Table North America Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Europe Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table North America Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure North America Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure North America Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure North America Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table North America Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table North America Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure North America Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure North America Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure North America Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table North America Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table North America Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure North America Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure North America Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure United States Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure Europe Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure Europe Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table Europe Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure Europe Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure Europe Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table Europe Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure Europe Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure Europe Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure Germany Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure France Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure China Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia and New ZealandNeurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure India Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure GCC Countries Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Nigeria Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Boehringer Ingelheim
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
Table Product and Service Introduction of Boehringer Ingelheim
Table Company Profile and Development Status of Teva
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
Figure Sales and Growth Rate Analysis of Teva
Figure Revenue and Market Share Analysis of Teva
Table Product and Service Introduction of Teva
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of Amarin
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amarin
Figure Sales and Growth Rate Analysis of Amarin
Figure Revenue and Market Share Analysis of Amarin
Table Product and Service Introduction of Amarin
Table Company Profile and Development Status of UCB
Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB
Figure Sales and Growth Rate Analysis of UCB
Figure Revenue and Market Share Analysis of UCB
Table Product and Service Introduction of UCB
Table Company Profile and Development Status of Merck
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
Figure Sales and Growth Rate Analysis of Merck
Figure Revenue and Market Share Analysis of Merck
Table Product and Service Introduction of Merck
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Addex Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Pharmaceutical
Figure Sales and Growth Rate Analysis of Addex Pharmaceutical
Figure Revenue and Market Share Analysis of Addex Pharmaceutical
Table Product and Service Introduction of Addex Pharmaceutical
Table Company Profile and Development Status of Bayer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
Figure Sales and Growth Rate Analysis of Bayer
Figure Revenue and Market Share Analysis of Bayer
Table Product and Service Introduction of Bayer
Table Company Profile and Development Status of Bial
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bial
Figure Sales and Growth Rate Analysis of Bial
Figure Revenue and Market Share Analysis of Bial
Table Product and Service Introduction of Bial
Table Company Profile and Development Status of Biogen Idec
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec
Figure Sales and Growth Rate Analysis of Biogen Idec
Figure Revenue and Market Share Analysis of Biogen Idec
Table Product and Service Introduction of Biogen Idec
Table Company Profile and Development Status of Yumanity Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yumanity Therapeutics
Figure Sales and Growth Rate Analysis of Yumanity Therapeutics
Figure Revenue and Market Share Analysis of Yumanity Therapeutics
Table Product and Service Introduction of Yumanity Therapeutics
Table Company Profile and Development Status of Asubio Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Asubio Pharmaceutical
Figure Sales and Growth Rate Analysis of Asubio Pharmaceutical
Figure Revenue and Market Share Analysis of Asubio Pharmaceutical
Table Product and Service Introduction of Asubio Pharmaceutical
Table Company Profile and Development Status of HLundbeck A/S
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HLundbeck A/S
Figure Sales and Growth Rate Analysis of HLundbeck A/S
Figure Revenue and Market Share Analysis of HLundbeck A/S
Table Product and Service Introduction of HLundbeck A/S
Table Company Profile and Development Status of Eisai
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai
Figure Sales and Growth Rate Analysis of Eisai
Figure Revenue and Market Share Analysis of Eisai
Table Product and Service Introduction of Eisai
Table Company Profile and Development Status of H.Lundbeck A/S
Table Sales, Revenue, Sales Price and Gross Margin Analysis of H.Lundbeck A/S
Figure Sales and Growth Rate Analysis of H.Lundbeck A/S
Figure Revenue and Market Share Analysis of H.Lundbeck A/S
Table Product and Service Introduction of H.Lundbeck A/S
Table Company Profile and Development Status of Alector
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alector
Figure Sales and Growth Rate Analysis of Alector
Figure Revenue and Market Share Analysis of Alector
Table Product and Service Introduction of Alector
-
